TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NEO

NeoGenomics Inc

Healthcare · Diagnostics & Research

18.90$ -2.7% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow NEO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
10.9% 6.4% 8.8% 7.5% 16.2% 5.7% 0.3% -5.5% -12.9% -0.3% 1.1% 0.7%
6.5% 7.2% 9.5% 9.4% 7.9% 7.4% 8.0% 11.0% 13.6% 12.3% 11.0% 9.3%
0.8% 3.5% 2.2% 2.7% 2.5% 2.4% 2.3% 4.6% 4.8% 4.2% 5.1% 5.7%
3.5% 5.2% 8.8% 11.0% 2.5% 2.7% 2.9% -14.4% 5.5%
-0.6% -1.9% -8.8% -12.7% 4.5% -7.9% -13.9% -0.9% -6.2% -4.3% -4.9% -4.4%
4.3% 2.2% 3.1% 5.7% 5.2% 4.9% 6.5% 13.2% 6.1% 4.9% 6.2% 3.7%
-11.0% -75.3% -2.7% -5.7% -50.5% -4.8% -35.9% -130.6% 0.1% 13.0% 1.9% -1.7%
0.0% 0.0% 36.0% 0.0% 3.5%
42.3% 0.9% -22.5% 1.1% -18.1% 2.7% 4.6% 3.1% 2.5%
-9.0% 57.7% 10.4% -2.8% -0.7% -1.3% 21.8% 68.4% -0.1% 0.0% 0.0% -27.7%
33.3% 58.6% -10.6% -1.7% 33.2% 39.0% 53.0% 149.8% 2.3% 0.8% 0.7% -27.5%
33.1% -10.3% -4.5% 0.1% -1.1% 39.9% 17.5% 13.7% -10.5% 13.4% 3.7% -28.5%
6.5% 4.2% 5.7% 1.8% 11.0% 0.8% -6.2% -18.8% -19.0% -5.2% -5.2% -3.0%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?